Psychopersonal characteristics of women with varying degrees of menopausal disorders
DOI:
https://doi.org/10.34287/MMT.3(50).2021.3Abstract
The perimenopausal period is the age of the highest spiritual and intellectual development of a woman; therefore, neurovegetative and psycho-emotional disorders of this period acquire a pecial medical and social value and require an interdisciplinary approach.
Purpose of the study. To identify the psychological characteristics of women with mild and moderate menopausal disorders in the perimenopausal period.
Materials and methods. A total of 51 women were examined in the perimenopausal period: I main group – 20 patients with a low degree of CS, II main group – 16 women with menopausal disorders of moderate severity; the control group consisted of 15 healthy women. The severity of menopausal syndrome was determined using a modified menopausal Cooperman's index. All patients underwent psychodiagnostic examination using reactive and personal anxiety scales according to Ch.D. Spielberg and J.L. Hanina, G. Eisenko's test questionnaire, the Women's Sexual Function Index (FSFI) questionnaire, used the SF-36 (Medical Outcomes Study Short Form) general questionnaire to assess quality of life.
Results. In women of the main groups, neurovegetative (14,5 ± 2,6 and 26,6 ± 4,2 points in the first and second groups of observation) and psycho-emotional disorders (4,9 ± 1,3 and 11,2 ± 1,6 points) prevailed. respectively). Hormone levels (FSH, E2, PRL) corresponded to perimenopausal values, but were significantly different from those of the control group. Identified individual-personal properties of women with the CS, in particular introversion and emotional instability. A comparative analysis on the SpielbergKhanin scales showed that more than half (55,0%) in the first main group and the majority (81,25%) of women in the second main group versus 33,35% in the control group (p ˂ 0,05), a high level of personal anxiety was diagnosed; the average level of situational anxiety was highest among women in group II – 54,83 ± 6,0 points versus 43,2 ± 5,3 points in the first group and 36,3 ± 4,8 points in patients without menopausal disorders (p ˂ 0,05). In 24 (77,42%) women of the main group, sexual dysfunction was detected, while its degree was greatest with moderately severe climacteric disorders. Menopausal disorders of varying severity, increased anxiety and neuroticism, sexual dysfunction affected the quality of life of patients.
Conclusion. Formed psychopersonal characteristics of women with varying degrees of menopausal disorders in the perimenopausal period.
References
Burchinskij SG. Vozmozhnosti kompleksnoj korrekcii reguljatornyh funkcij centralnoj nervnoj sistemy pri psihosomaticheskoj patologii. Nevrologija. 2015; 2(58):100–105.
Burchinskij SG. Klіmakterichnij sindrom: mozhlivostі ta perspektivi nejro-farmakologіchnoї korekcії. Lіki.2006;1(2): 17–24.
Vdovichenko JuP, Gurzhenko OJu. Porushennja ta principi dіagnostiki seksualnoi funkcії zhіnok u perimenopauzal'nomu vіcі. Zdorov'e muzhchiny.2017; 4 (63): 84–94.
Dnіstrjanska, AP. Kompleksna korekcіja klіnіchnih projavіv perimenopauzalnogo perіodu u zhіnok. Zdorov'e zhenshhiny.2014; 10 (96):157–162.
Kolesnikova OV, Jares'ko MV. Osoblivostі varіabelnostі sercevogo ritmu u zhіnok v perimenopauzі. Vіsnik Vіnnic'kogo nacіonal'nogo unіversitetu.2015 ;2(19): 374–379.
Kolotusha, VG. Psihopatologіchnі projavi u zhіnok v perimenopauzalnij perіod ta mozhlivostі їh korekcії negormonal'nimi metodami. Lіki Ukraїni. Preventivna medicina. Psihonevrologіja.2014; 3(4):16–19.
Kuz'mіnova NV. (2015). Dіagnostika ta medikamentozna korekcіja vegetativnih rozladіv u zhіnok z arterіalnoju gіpertenzієju v peri- і po- stmenopauzal'nij perіodi. Zdorov'e zhenshhiny.2015; 2 (98): 192–199.
Ragimova VV, Alieva JeM, Sultanova SG. (2018). Osobennosti projavlenij klimaktericheskogo sindroma u zhenshhin v postmenopauzalnyj period v sovremennyh uslovijah. Zdorov'e zhenshhiny.2018; 1 (127):68–72.
Rajgorodskij DJa. Prakticheskaja psihodiagnostika. Metodiki i testy: uchebnoe posobie. Samara: Izdatel'skij Dom«BAHRAH–M».2011.
Tatarchuk TF, Islamova AO. Efimenko OA. (2015). Klimaktericheskij sindrom kak pervoe klinicheskoe projavlenie perimenopauzy. Reproduktivnaja jendokrinologija.2015; 1 (21):52–56.
Tatarchuk, TF, Tobі de Vіl'єrs.Nacіonalnij konsensus shhodo veden- nja pacієntok u klіmakterії. Reproduktivnaja jendokrinologija 2016; 1 (27):8-25: doi: http:// dx.doi.org/10.18370/2309-4117.2016.27.8-25.
De VilliersTJ , Gass ML,Haines CJ. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric.2013;16: 203–204.
Kardioplaneta. Medicinskie programmy; 2017. Rezhim dostupa http://cardioplaneta.ru/program/337-sf-36-health-status-survey.html.Rosen RS
Brown C, Heiman J, Leiblum SR, MestonC.The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther.2000;26:191.
